Center for Endoscopic Research and Therapeutics (CERT), The University of Chicago Medicine, Chicago, Illinois.
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Gastroenterology. 2018 May;154(7):1911-1924. doi: 10.1053/j.gastro.2017.12.046. Epub 2018 Feb 16.
The role of endoscopic ultrasound (EUS) has transitioned from a diagnostic to a therapeutic one over the past 40 years. With the advent of curvilinear array echoendoscopes in the 1990s with an accessory channel, multiple tools and devices have been developed and used for a variety of transluminal interventions. EUS provides a viable option and is becoming the procedure of choice for many interventions, including bile and pancreatic duct drainage, guiding angiotherapy, pancreatic fluid collection management, gallbladder drainage, and creating a gastrojejunostomy. Although reports demonstrate the technical success of these interventions, there is tremendous study heterogeneity and a relative lack of controlled randomized trials, which may limit our understanding of their role and utility. Furthermore, adverse events are relatively common and occasionally severe. Despite the limitations, available data strongly indicate the efficacy of EUS interventions when performed by well-trained endosonographers in carefully selected patients and managed in a multidisciplinary setting.
在过去的 40 年里,内镜超声(EUS)的作用已经从诊断转变为治疗。随着 20 世纪 90 年代带有辅助通道的环扫超声内镜的出现,已经开发和使用了多种工具和设备来进行多种经腔介入治疗。EUS 提供了一种可行的选择,并且正在成为许多介入治疗的首选方法,包括胆汁和胰管引流、引导血管内治疗、胰液收集管理、胆囊引流和胃空肠吻合术。尽管报告显示这些介入治疗的技术成功率很高,但存在巨大的研究异质性和相对缺乏对照随机试验,这可能限制了我们对其作用和用途的理解。此外,不良事件相对常见,偶尔也很严重。尽管存在这些局限性,但现有数据强烈表明,在经过良好培训的超声内镜医师在仔细选择的患者中进行 EUS 介入治疗,并在多学科环境中进行管理时,其具有疗效。